$17 Million Center for Psychedelic and Consciousness Research to investigate magic mushrooms

The largest psychedelic research center in the world, and the first of its kind in the United States, will open at Johns Hopkins Medicine in Maryland. Funded by $17 million from private donors, the Center for Psychedelic and Consciousness Research will conduct research into the use of psychedelic drugs in the treatment of addiction, PTSD, depression, Alzheimer's disease and more.

, with a broad mandate. According to a press release, researchers will investigate how psilocybin affects"behavior, brain function, learning and memory, the brain's biology and mood." Potential applications under investigation will include therapies for opioid addiction, Alzheimer's, PTSD, eating disorders, alcoholism and even post-treatment Lyme disease syndrome.

Subsequent research has already demonstrated promising therapeutic benefits in the treatment of nicotine addiction and in mitigating the anxiety and depression associated with high mortality diseases, including cancer.

They got a number?

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Psychedelic Drugs Draw Some Investor Attention—and Much SkepticismA fringe group of entrepreneurs and investors see the emerging practice of using psychedelic substances for mental-health treatment as a business opportunity. Traditional health-care investors aren’t so sure. Everyone would have to admit invisible friends are real. Probably because they tried them as teenagers and they still scare the hell out of them. Can’t sell that many mushrooms, psychedelics are not ongoing therapy. A few good trips and you should be done. Low lifetime customer value Weed on the other hand...
Source: WSJ - 🏆 98. / 63 Read more »